1. Home
  2. Labeler Index
  3. Carilion Materials Management
  4. 68151-4734
  5. Product Images: Cymbalta

Product Images Cymbalta

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 11 images provide visual information about the product associated with Cymbalta NDC 68151-4734 by Carilion Materials Management, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Structural Formula - cymbalta 01

Structural Formula - cymbalta 01

Figure 3 - cymbalta 02

Figure 3 - cymbalta 02

Figure 4 - cymbalta 03

Figure 4 - cymbalta 03

Figure 5 - cymbalta 13

Figure 5 - cymbalta 13

Figure 6 - cymbalta 14

Figure 6 - cymbalta 14

Figure 7 - cymbalta 15

Figure 7 - cymbalta 15

The text describes a chart or graph that shows the percentage of improvement in pain from baseline in patients who received a placebo and those who received CYM60/120 mg once a day. The percentages range from 0% to 100%, with the highest percentage of improvement at 100% in the group receiving CYM60/120 mg once a day. The chart also shows different levels of percentage improvement in pain from baseline at different points on the graph.*

Figure 8 - cymbalta 16

Figure 8 - cymbalta 16

This appears to be a chart comparing the percentage of patients who have improved from baseline pain scores when taking either a placebo or CYMB0 mg once daily. The chart shows that 100% of patients improved when taking the CYMB0 mg once daily medication, represented by a solid line. The dotted line represents the improvement percentage for patients taking a placebo. The x-axis of the chart shows the levels of improvement in increments of 10%, and the y-axis represents the percentage of patients who have achieved that level of improvement.*

Figure 9 - cymbalta 17

Figure 9 - cymbalta 17

This text describes a graph or chart showing the percentage of patients who improved while taking a placebo versus CYM60/120 mg once daily. The chart also includes percentage improvement in pain from baseline.*

Figure 1 - cymbalta 18

Figure 1 - cymbalta 18

The graph shows the proportion of patients with relapse over time (in days) after randomization for a treatment group (CYMBALTA) and a placebo group. The X-axis represents the number of days, ranging from 0 to 250, and the Y-axis represents the proportion of patients with relapse, ranging from 0 to 1. The CYMBALTA treatment group has a lower proportion of patients with relapse compared to the placebo group.*

Figure 2 - cymbalta 19

Figure 2 - cymbalta 19

Label Image - lbl681514734

Label Image - lbl681514734

This is a medication description for Cymbalta (generic name: Duloxetine) which is a 20mg delayed-release capsule produced by Lilly. The expiration date of the medication is 07/14 and the manufacturer's lot number is W010414SN20. It is a prescription-only drug with the code PDM: 4734.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.